Texas Instruments (TI) (NASDAQ: TXN) today introduced five new next-generation power management integrated circuits that efficiently acquire and manage microwatts (uW) to milliwatts (mW) of power harvested from light, heat or mechanical energy sources. The bq25570, bq25505, TPS62740, TPS62737 and TPS62736 maintain the industry’s lowest levels of active quiescent current and enable battery-free operation to wireless sensor networks, monitoring systems, wearable medical devices, mobile accessories and other applications with limited access to power. To order samples and development kits, visit: www.ti.com/energyharvesting-pr.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/54051-texas-instruments-next-wave-of-energy-harvesting-design
Back App proven to improve back pain and prevent office workers from falling victim to Sitting Disease, is a chair that is very different from all others.
Back pain is a modern epidemic, with recent high profile victims including UK Prime Minister David Cameron, model Jodie Kidd and tennis ace Andy Murray.
With 80% of people experiencing some form of back pain in their lifetime and the rise of tablet computers creating a generation hunched over screens - dubbed the ‘iPosture’ generation – the Back App is more relevant than ever in the effort to combat Sitting Disease which, in addition to back pain, has been linked to cardiovascular illness and cancer.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/51361-back-app-guarantee-improved-back-pain
Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, has announced the launch of ScienceCloud, a new SaaS-based information management and collaboration workspace. ScienceCloud advances collaborative drug discovery with a new generation of integrated applications built on a scalable, cloud-based scientific platform. With no software to manage and no hardware to maintain, ScienceCloud improves operational excellence in globally networked research, significantly reducing IT cost and effort.
To view Multimedia News Release, go to http://www.multivu.com/mnr/65595-sciencecloud-software-by-accelrys-advances-collaborative-drug-discovery
Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management solutions, today announced its next-generation mobile strategy for the laboratory―to provide a flexible and secure mobile computing environment that effectively connects scientists, equipment and materials in today’s laboratories where an increasing number and variety of mobile devices, from smart phones to tablet computers, are in use. With over a decade of experience in pioneering paperless, mobile computing and wireless compliance capabilities in regulated laboratories, Accelrys will empower organizations to deploy purpose-built mobile applications in the lab from research to manufacturing, satisfying specific workflow requirements in accordance with Good Manufacturing Practice.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/65931-accelrys-capture-drives-next-generation-mobility-in-the-laboratory
Beim traditionellen Volkswagen-Konzern-Treffen am Vorabend des Genfer Autosalons gab es eine spannende Frage – welche Weltpremieren, welche Studien würden hier vorab präsentiert, welche erst am ersten Messetag. Denn angesichts der wahren Neuheitenflut war eine Auswahl unumgänglich. Nun, man entschied sich für eine gesunde Mischung und fand damit bei den über 1.200 geladenen Gästen großen Anklang. Die dritte Generation des Audi TT, der Huracan als Nachfolger des Lamborghini Gallardo, der „Rembrandt Bugatti“ als weitere Sonderedition des Veyron 16,4 Grand Sport Vitesse, der Continental GT Speed als schnellster Bentley aller Zeiten sowie der Seat Leon Cupra zeigten das Hier und Jetzt. Die Skoda-Designstudie „VisionC“ und das sechssitzige Konzeptfahrzeug „Clipper“ von Giugiaro dagegen unterschiedliche Ansätze, wie die automobile Zukunft aussehen könnte. Für den Spagat zwischen Konzeptfahrzeug und Serie zuständig aren der T-ROC, mit dem Volkswagen zwischen Tiguan und Touareg eine neue SUV-Baureihe etablieren wird und die Alltrack-Studie für den VW Multivan, der schon sehr bald auf unseren Straßen zu sehen sein dürfte. Ein vielfältigeres Angebot kann derzeit kein anderer Autokonzern bieten.
This week Hill-Rom (NYSE: HRC) is featuring the Progressa® bed system, the next generation of intensive care unit (ICU) bed systems, at the American Organization of Nurse Executives (AONE) annual meeting in Orlando, Fla. The Progressa bed system is a therapeutic system designed to treat and prevent complications of immobility. It features a state-of-the-art design that supports treatment goals and was engineered to help address patient migration via its StayInPlace™ technology.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/66137-hill-rom-new-progressa-bed-system
Hyundai introduced its all-new seventh-generation 2015 Sonata at the New York International Auto Show. Following the incredible success of the outgoing Sonata, the all-new generation offers a more refined look through a new Fluidic Sculpture 2.0 design language, stiffer body structure, better ride quality, reduced noise, vibration and harshness and advanced safety and convenience features. Sonata truly democratizes the premium design and convenient technology of the Genesis sedan for the mid-size class. The new 2015 Hyundai Sonata will be built at the Hyundai Motor Manufacturing Alabama plant in Montgomery, Ala. and go on sale early this summer.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/7118551-2014-ny-international-auto-show-best-sellers-hyundai-toyota-subaru-kbb
Global health service company Cigna (NYSE: CI) and Samsung Electronics Co. Ltd., are delivering the next generation of smart health coaching service: Coach by Cigna as a part of S Health* on Samsung Galaxy S 5. The new digital health guidance system is designed to help the Galaxy S 5 users worldwide make better health a habit.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7221131-samsung-s-health-app-expands-with-coach-by-cigna/
Maricopa County Sheriff’s Office Deploys DataDirect Networks for State-of-the-Art Video Surveillance Storage Archive as Part of ‘Tough on Crime’ Stance. Third Largest Sheriff's Office in US Deploys DDN Storage to Enable 10x Performance Increase and Extended Video Retention for Next Generation Jail-System Security to Video Coverage
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7116951-maricopa-county-sheriff-office-deploys-datadirect-networks-state-of-art-video-surveillance-storage-archive/
On Sunday, August 24, truth®, the nation’s largest and longest running youth smoking prevention campaign, premiered the latest advertisements in its new Finish It campaign, titled “Unpaid” and “Response”. Both aired during the hugely popular MTV Video Music Awards broadcast — an annual music awards ceremony that attracts millions of viewers and sparks immediate cultural conversations. Teen smoking rates are at their lowest levels in 22 years, and through the Finish It campaign, truth aims to enlist this generation to end smoking for good.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7304851-truth-launches-finish-it-campaign-challenges-teens-to-become-first-smoke-free-generation/
Phenogen Sciences, Inc. today announced the availability of BREVAGenplus, an easy-to-use predictive risk test for the millions of women at risk of developing sporadic, or non-hereditary, breast cancer. The test is an enhancement of the company’s first generation product, BREVAGen®. BREVAGenplus assesses both clinical risk factors and genetic markers known to be associated with sporadic, or non-hereditary, breast cancer to determine a woman’s five-year and lifetime risk of developing the disease. The test is designed to facilitate better informed decisions about breast cancer screening and preventive treatment plans for Caucasian, Hispanic and African-American women, age 35 years or above, who have not had breast cancer, lobular carcinoma in situ (LCIS) or ductal carcinoma in situ (DCIS), and have one or more risk factors for developing breast cancer.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7337351-phenogen-sciences-introduces-brevagenplus-breast-cancer-risk-assessment-test/
